Matthew Perrone

Healthcare

FDA panel backs Gilead Sciences’ hepatitis C drug

October 25, 2013 8:46 pm

FILE - In this Feb. 19, 2013 file photo, hydrocodone bitartrate and acetaminophen pills, also known as Vicodin, are arranged for a photo at a pharmacy in Montpelier, Vt. The Food and Drug Administration on Thursday, Oct. 24, 2013 recommended new restrictions on prescription medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S. (AP Photo/Toby Talbot, File)

News

FDA wants limits on most prescribed painkillers

Matthew Perrone -

October 25, 2013 12:03 am

Healthcare

Companies offer health benefits to transgender workers

Matthew Perrone -

October 24, 2013 3:52 pm

The Food and Drug Administration holds a public meeting this week to review two experimental medications from Johnson & Johnson and Gilead Sciences. The new drugs, if approved, could offer a quicker, more effective approach to eliminating hepatitis C, a blood-borne disease blamed for 15,000 deaths in the U.S. this year. (Photo: Thinkstock)

News

FDA reviews 2 promising new drugs for hepatitis C

Associated Press, Matthew Perrone -

October 22, 2013 4:00 am

News

FDA approves first pre-surgical breast cancer drug

Matthew Perrone -

September 30, 2013 2:11 pm

Healthcare

FDA requires tracking codes on medical implants

Matthew Perrone -

September 20, 2013 6:48 pm

This undated photo provided by Roche, shows the initial treatment drug Perjeta The U.S. Food and Drug Administration has issued a positive review of Perjeta, a breast cancer drug from Roche that could soon become the first pharmaceutical option approved for treating early-stage disease before surgery. (AP Photo/Roche)

Healthcare

FDA panel backs drug for early stage breast cancer

Matthew Perrone -

September 12, 2013 9:23 pm

News

FDA: Roche drug works in early-stage breast cancer

Matthew Perrone -

September 10, 2013 9:20 pm

News

FDA orders starker warnings on opioid painkillers

Matthew Perrone -

September 10, 2013 9:16 pm

News

J&J recalls Infant Motrin due to plastic specks

Matthew Perrone -

September 6, 2013 10:41 pm

1...8910...16 Page 9 of 16

Matthew Perrone

FDA panel backs Gilead Sciences’ hepatitis C drug

FDA wants limits on most prescribed painkillers

Companies offer health benefits to transgender workers

FDA reviews 2 promising new drugs for hepatitis C

FDA approves first pre-surgical breast cancer drug

FDA requires tracking codes on medical implants

FDA panel backs drug for early stage breast cancer

FDA: Roche drug works in early-stage breast cancer

FDA orders starker warnings on opioid painkillers

J&J recalls Infant Motrin due to plastic specks

NEWS

POLICY

COMMENTARY

RESTORING AMERICA